Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
    • Transcripts
    • AGM Invitations
  • inderesTV
  • Forum
  • About Us
    • Our Coverage
    • Team

You seem to be using a wider screen, would you like to enable a wider viewing experience on this page?

Eltel Q3´25: Execution on strategy continues

By Christoffer JennelAnalyst
Eltel

Eltel published its third-quarter report today, showing negative organic growth, while the EBITA margin was in line with our analyst expectations. Listen to the interview with CEO Håkan Dahlström, where he discusses the Q3 figures, his thoughts on 2025 in general, and what to expect in 2026.

Read the report here. 

Stay up to date
Company management interviews

Recent videos

Scanfil Q4’25: Horizontal operational progress
09.03.2026, 10.26 Scanfil
HCA Morgenbørs 06/03 - Investorerne finder lidt ro efter en uge præget af usikkerhed
06.03.2026, 09.25 Zealand Pharma
Aiforia, Webcast, H2, 2025
06.03.2026, 09.00 Aiforia Technologies
Nightingale, Webcast, Half-year financial report 1 July–31 December 2025
05.03.2026, 13.00 Nightingale Health
Solwers, Webcast, Q4'25
05.03.2026, 11.00 Solwers
View all videos
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • X (Twitter)
Get in touch
  • info@hcandersencapital.dk
  • Bredgade 23B, 2. sal
    1260 København K
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.